⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DCTH News
Delcath Systems Inc
Form 8-K
sec.gov
DCTH
Delcath Systems Reports Fourth Quarter and Full Year 2025 Results
businesswire.com
DCTH
Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
businesswire.com
DCTH
Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
DCTH
Delcath Systems Announces Publication of Subgroup Analyses of the Phase 3 FOCUS Study of Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma
businesswire.com
DCTH
Delcath Systems Announces Publication of 10-Year Single-Center Experience with Percutaneous Hepatic Perfusion in Liver-Dominant Metastatic Uveal Melanoma
businesswire.com
DCTH
Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program
businesswire.com
DCTH
Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma
businesswire.com
DCTH
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
DCTH
Delcath Systems to Participate in Upcoming Investor Conferences
businesswire.com
DCTH